Document is current

Any future updates will be listed below

Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuation

Crossref DOI link: https://doi.org/10.1186/ar4675

Published Online: 2014-07-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark